These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3034027)
1. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications. Unger T; Ganten D; Lang RE Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027 [TBL] [Abstract][Full Text] [Related]
2. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. Moursi MG; Ganten D; Lang RE; Unger T J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591 [TBL] [Abstract][Full Text] [Related]
3. Tissue converting enzyme inhibition and cardiovascular effects of converting enzyme inhibitors. Unger T; Schölkens BA; Ganten D; Lang RE Clin Exp Hypertens A; 1987; 9(2-3):417-26. PubMed ID: 3038405 [TBL] [Abstract][Full Text] [Related]
4. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)]. Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498). Unger T; Moursi M; Ganten D; Hermann K; Lang RE J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465 [TBL] [Abstract][Full Text] [Related]
6. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats. Unger T; Ganten D; Lang RE; Schölkens BA J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494 [TBL] [Abstract][Full Text] [Related]
7. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. Unger T; Ganten D; Lang RE; Schölkens BA J Cardiovasc Pharmacol; 1985; 7(1):36-41. PubMed ID: 2580148 [TBL] [Abstract][Full Text] [Related]
8. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. Unger T; Fleck T; Ganten D; Lang RE; Rettig F Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269 [TBL] [Abstract][Full Text] [Related]
9. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [TBL] [Abstract][Full Text] [Related]
10. Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system. Saito H; Nakamaru M; Rakugi H; Mikami H; Ogihara T; Inagami T Clin Exp Pharmacol Physiol; 1990 Nov; 17(11):745-53. PubMed ID: 2150362 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors. Gohlke P; Urbach H; Schölkens B; Unger T J Pharmacol Exp Ther; 1989 May; 249(2):609-16. PubMed ID: 2542535 [TBL] [Abstract][Full Text] [Related]
12. Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors. Unger T; Ganten D; Lang RE J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S75-81. PubMed ID: 2438496 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. Linz W; Schölkens BA; Han YF J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S91-9. PubMed ID: 2438498 [TBL] [Abstract][Full Text] [Related]
14. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition. Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288. Gohlke P; Schölkens B; Henning R; Urbach H; Unger T J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S32-6. PubMed ID: 2483426 [TBL] [Abstract][Full Text] [Related]
16. Intrarenal angiotensin converting enzyme inhibition in spontaneously hypertensive rats. Aihara H; Ogawa H; Kasuya A; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S Eur J Pharmacol; 1999 May; 373(1):35-40. PubMed ID: 10408249 [TBL] [Abstract][Full Text] [Related]
17. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats. Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats. Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150 [TBL] [Abstract][Full Text] [Related]